Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs (Q61961406)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

G Pratesi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D Polizzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L Dal Bo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Zunino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Biochemical Pharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

77-82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

Bcl-2 and the regulation of programmed cell death

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Inactivation of Bcl-2 by phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Role of apoptotic response in cellular resistance to cytotoxic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Doxorubicin disaccharide analogue: apoptosis-related improvement of efficacy in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Apoptosis meets signal transduction: elimination of a BAD influence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Phosphorylation of Bcl-2 is a marker of M phase events and not a determinant of apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900300-2

10.1016/S0006-2952(00)00300-2

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10807947%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference